Literature DB >> 24561592

Survival of airborne MS2 bacteriophage generated from human saliva, artificial saliva, and cell culture medium.

Zhili Zuo1, Thomas H Kuehn, Aschalew Z Bekele, Sunil K Mor, Harsha Verma, Sagar M Goyal, Peter C Raynor, David Y H Pui.   

Abstract

Laboratory studies of virus aerosols have been criticized for generating airborne viruses from artificial nebulizer suspensions (e.g., cell culture media), which do not mimic the natural release of viruses (e.g., from human saliva). The objectives of this study were to determine the effect of human saliva on the infectivity and survival of airborne virus and to compare it with those of artificial saliva and cell culture medium. A stock of MS2 bacteriophage was diluted in one of three nebulizer suspensions, aerosolized, size selected (100 to 450 nm) using a differential mobility analyzer, and collected onto gelatin filters. Uranine was used as a particle tracer. The resulting particle size distribution was measured using a scanning mobility particle sizer. The amounts of infectious virus, total virus, and fluorescence in the collected samples were determined by infectivity assays, quantitative reverse transcription-PCR (RT-PCR), and spectrofluorometry, respectively. For all nebulizer suspensions, the virus content generally followed a particle volume distribution rather than a number distribution. The survival of airborne MS2 was independent of particle size but was strongly affected by the type of nebulizer suspension. Human saliva was found to be much less protective than cell culture medium (i.e., 3% tryptic soy broth) and artificial saliva. These results indicate the need for caution when extrapolating laboratory results, which often use artificial nebulizer suspensions. To better assess the risk of airborne transmission of viral diseases in real-life situations, the use of natural suspensions such as saliva or respiratory mucus is recommended.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24561592      PMCID: PMC3993287          DOI: 10.1128/AEM.00056-14

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  39 in total

1.  Effect of temperature, relative humidity and medium on the aerosol stability of infectious bovine rhinotracheitis virus.

Authors:  M A Elazhary; J B Derbyshire
Journal:  Can J Comp Med       Date:  1979-04

2.  Effects of relative humidity and spraying medium on UV decontamination of filters loaded with viral aerosols.

Authors:  Myung-Heui Woo; Adam Grippin; Diandra Anwar; Tamara Smith; Chang-Yu Wu; Joseph D Wander
Journal:  Appl Environ Microbiol       Date:  2012-06-08       Impact factor: 4.792

3.  Control of aerosol contaminants in indoor air: combining the particle concentration reduction with microbial inactivation.

Authors:  Sergey A Grinshpun; Atin Adhikari; Takeshi Honda; Ki Youn Kim; Mika Toivola; K S Ramchander Rao; Tiina Reponen
Journal:  Environ Sci Technol       Date:  2007-01-15       Impact factor: 9.028

4.  Virus inactivation mechanisms: impact of disinfectants on virus function and structural integrity.

Authors:  Krista Rule Wigginton; Brian M Pecson; Thérese Sigstam; Franziska Bosshard; Tamar Kohn
Journal:  Environ Sci Technol       Date:  2012-10-26       Impact factor: 9.028

5.  Airborne stability of tailless bacterial viruses S-13 and MS-2.

Authors:  E J Dubovi; T G Akers
Journal:  Appl Microbiol       Date:  1970-04

6.  Detection of Influenza A virus in porcine oral fluid samples.

Authors:  Susan E Detmer; Devi P Patnayak; Yin Jiang; Marie R Gramer; Sagar M Goyal
Journal:  J Vet Diagn Invest       Date:  2011-03       Impact factor: 1.279

7.  Multiple components contribute to ability of saliva to inhibit influenza viruses.

Authors:  M R White; E J Helmerhorst; A Ligtenberg; M Karpel; T Tecle; W L Siqueira; F G Oppenheim; K L Hartshorn
Journal:  Oral Microbiol Immunol       Date:  2009-02

8.  Airborne influenza virus detection with four aerosol samplers using molecular and infectivity assays: considerations for a new infectious virus aerosol sampler.

Authors:  P Fabian; J J McDevitt; E A Houseman; D K Milton
Journal:  Indoor Air       Date:  2009-05-26       Impact factor: 5.770

9.  Physical collection efficiency of filter materials for bacteria and viruses.

Authors:  Nancy Clark Burton; Sergey A Grinshpun; Tiina Reponen
Journal:  Ann Occup Hyg       Date:  2006-10-14

Review 10.  Bacterial and viral pathogens in saliva: disease relationship and infectious risk.

Authors:  Jørgen Slots; Henrik Slots
Journal:  Periodontol 2000       Date:  2011-02       Impact factor: 7.589

View more
  20 in total

1.  Resistance of Aerosolized Bacterial Viruses to Relative Humidity and Temperature.

Authors:  Daniel Verreault; Mélissa Marcoux-Voiselle; Nathalie Turgeon; Sylvain Moineau; Caroline Duchaine
Journal:  Appl Environ Microbiol       Date:  2015-08-07       Impact factor: 4.792

2.  Determination of the distribution of infectious viruses in aerosol particles using water-based condensational growth technology and a bacteriophage MS2 model.

Authors:  Maohua Pan; Leah Carol; John A Lednicky; Arantzazu Eiguren-Fernandez; Susanne Hering; Z Hugh Fan; Chang-Yu Wu
Journal:  Aerosol Sci Technol       Date:  2019-03-19       Impact factor: 2.908

3.  Transformative Approach To Investigate the Microphysical Factors Influencing Airborne Transmission of Pathogens.

Authors:  Mara Otero Fernandez; Richard J Thomas; Henry Oswin; Allen E Haddrell; Jonathan P Reid
Journal:  Appl Environ Microbiol       Date:  2020-11-10       Impact factor: 4.792

4.  Effect of selected sampling media, flow rate, and time on the sampling efficiency of a liquid impinger packed with glass beads for the collection of airborne viruses.

Authors:  Yen-Chi Chen; I-Jen Wang; Chih-Ching Cheng; Yu-Chiao Wu; Chun-Hsuan Bai; Kuo-Pin Yu
Journal:  Aerobiologia (Bologna)       Date:  2021-01-13       Impact factor: 2.376

Review 5.  Aerobiology: Experimental Considerations, Observations, and Future Tools.

Authors:  Allen E Haddrell; Richard J Thomas
Journal:  Appl Environ Microbiol       Date:  2017-08-17       Impact factor: 4.792

6.  Airborne SARS-CoV-2 Is Rapidly Inactivated by Simulated Sunlight.

Authors:  Michael Schuit; Shanna Ratnesar-Shumate; Jason Yolitz; Gregory Williams; Wade Weaver; Brian Green; David Miller; Melissa Krause; Katie Beck; Stewart Wood; Brian Holland; Jordan Bohannon; Denise Freeburger; Idris Hooper; Jennifer Biryukov; Louis A Altamura; Victoria Wahl; Michael Hevey; Paul Dabisch
Journal:  J Infect Dis       Date:  2020-07-23       Impact factor: 5.226

7.  Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces.

Authors:  Shanna Ratnesar-Shumate; Gregory Williams; Brian Green; Melissa Krause; Brian Holland; Stewart Wood; Jordan Bohannon; Jeremy Boydston; Denise Freeburger; Idris Hooper; Katie Beck; John Yeager; Louis A Altamura; Jennifer Biryukov; Jason Yolitz; Michael Schuit; Victoria Wahl; Michael Hevey; Paul Dabisch
Journal:  J Infect Dis       Date:  2020-06-29       Impact factor: 5.226

8.  Increasing Temperature and Relative Humidity Accelerates Inactivation of SARS-CoV-2 on Surfaces.

Authors:  Jennifer Biryukov; Jeremy A Boydston; Rebecca A Dunning; John J Yeager; Stewart Wood; Amy L Reese; Allison Ferris; David Miller; Wade Weaver; Nathalie E Zeitouni; Aaron Phillips; Denise Freeburger; Idris Hooper; Shanna Ratnesar-Shumate; Jason Yolitz; Melissa Krause; Gregory Williams; David G Dawson; Artemas Herzog; Paul Dabisch; Victoria Wahl; Michael C Hevey; Louis A Altamura
Journal:  mSphere       Date:  2020-07-01       Impact factor: 4.389

9.  Aerosolization of a Human Norovirus Surrogate, Bacteriophage MS2, during Simulated Vomiting.

Authors:  Grace Tung-Thompson; Dominic A Libera; Kenneth L Koch; Francis L de Los Reyes; Lee-Ann Jaykus
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

10.  An efficient virus aerosol sampler enabled by adiabatic expansion.

Authors:  Haoran Yu; Nima Afshar-Mohajer; Alexandros D Theodore; John A Lednicky; Z Hugh Fan; Chang-Yu Wu
Journal:  J Aerosol Sci       Date:  2018-01-04       Impact factor: 3.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.